Home / News / India News / Article / Pfizer withdraws emergency use request for its COVID-19 vaccine in India

Pfizer withdraws emergency use request for its COVID-19 vaccine in India

Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the DCGI for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain

  • WhatsAppBookmarkBookmark
Listen to this article :
Vials with COVID-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer. Pic/AFP

Vials with COVID-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer. Pic/AFP

Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India.

Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.

Read Next Story
SC posts final hearing in pleas challenging Bombay HC order over Maratha jobs quota on March 8›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All